Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 CNS 2 Other hematologic neoplasm 1 Genitourinary 1 Classical hematology 1

Conditions

Prostatic Neoplasms 1645 Carcinoma, Renal Cell 505 Urinary Bladder Neoplasms 462 Carcinoma, Transitional Cell 236 Breast Neoplasms 228 Kidney Neoplasms 218 Neoplasms 194 Carcinoma, Non-Small-Cell Lung 173 Colorectal Neoplasms 172 Ovarian Neoplasms 163 Melanoma 163 Neoplasm Metastasis 144 Lung Neoplasms 128 Non-Muscle Invasive Bladder Neoplasms 107 Pancreatic Neoplasms 103 Stomach Neoplasms 101 Uterine Cervical Neoplasms 93 Squamous Cell Carcinoma of Head and Neck 86 Endometrial Neoplasms 84 Carcinoma, Hepatocellular 77 Sarcoma 76 Esophageal Neoplasms 72 Head and Neck Neoplasms 70 Triple Negative Breast Neoplasms 67 Adenocarcinoma 67 Colonic Neoplasms 53 Testicular Neoplasms 52 Disease 47 Wilms Tumor 46 Urologic Neoplasms 46

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoviridae Infections × Genitourinary × 1 year × Clear all

NCT02143804 2026-04-02

exBOND

CG Oncology, Inc.

Phase 2 Withdrawn

Adenoviridae Infections, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡